Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gibbs

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Thoracic and Cardiovascular Surgery|July 24, 2012
Development of a diagnosis- and procedure-based risk model for 30-day outcome after pediatric cardiac surgerySonya Crowe, Kate L Brown, Christina Pagel, et al.
Journal of Clinical Pharmacology|November 7, 2017
Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque PsoriasisRichard G Langley, Sree Kasichayanula, Mona Trivedi, et al.
Leukemia & Lymphoma|September 17, 2004
Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphomaAsher Chanan-Khan, Tariq Islam, Arif Alam, et al.
Anti-Cancer Drugs|September 3, 2013
MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical modelsJuan J Gu, Francisco J Hernandez-Ilizaliturri, Cory Mavis, et al.
Annals of Clinical Biochemistry|May 25, 2011
Transient congenital hypothyroidism due to thyroid-stimulating hormone receptor blocking antibodies: a case seriesCarol Evans, John W Gregory, John Barton, et al.
Journal of Gastrointestinal Oncology|December 4, 2012
Treatment of locally advanced unresectable pancreatic cancer: a 10-year experienceNadia K Malik, Kilian Salerno May, Rameela Chandrasekhar, et al.
Blood|October 9, 2010
Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cellsScott H Olejniczak, Jennifer Blickwedehl, Alan Belicha-Villanueva, et al.
Journal of Gastrointestinal Oncology|December 3, 2013
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancerGary Y Yang, Nadia K Malik, Rameela Chandrasekhar, et al.
Pharmacological Research|May 12, 2009
Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including humanMark S Warren, Noa Zerangue, Katie Woodford, et al.
BMJ (Clinical Research Ed.)|March 22, 2013
Act now against new NHS competition regulations: an open letter to the BMA and the Academy of Medical Royal Colleges calls on them to make a joint public statement of opposition to the amended section 75 regulationsJacky Davis, Ian Banks, David Wrigley, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Thoracic and Cardiovascular Surgery|July 24, 2012
Development of a diagnosis- and procedure-based risk model for 30-day outcome after pediatric cardiac surgerySonya Crowe, Kate L Brown, Christina Pagel, et al.
Journal of Clinical Pharmacology|November 7, 2017
Pharmacokinetics, Immunogenicity, and Efficacy of Etanercept in Pediatric Patients With Moderate to Severe Plaque PsoriasisRichard G Langley, Sree Kasichayanula, Mona Trivedi, et al.
Leukemia & Lymphoma|September 17, 2004
Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphomaAsher Chanan-Khan, Tariq Islam, Arif Alam, et al.
Anti-Cancer Drugs|September 3, 2013
MLN2238, a proteasome inhibitor, induces caspase-dependent cell death, cell cycle arrest, and potentiates the cytotoxic activity of chemotherapy agents in rituximab-chemotherapy-sensitive or rituximab-chemotherapy-resistant B-cell lymphoma preclinical modelsJuan J Gu, Francisco J Hernandez-Ilizaliturri, Cory Mavis, et al.
Annals of Clinical Biochemistry|May 25, 2011
Transient congenital hypothyroidism due to thyroid-stimulating hormone receptor blocking antibodies: a case seriesCarol Evans, John W Gregory, John Barton, et al.
Journal of Gastrointestinal Oncology|December 4, 2012
Treatment of locally advanced unresectable pancreatic cancer: a 10-year experienceNadia K Malik, Kilian Salerno May, Rameela Chandrasekhar, et al.
Blood|October 9, 2010
Distinct molecular mechanisms responsible for bortezomib-induced death of therapy-resistant versus -sensitive B-NHL cellsScott H Olejniczak, Jennifer Blickwedehl, Alan Belicha-Villanueva, et al.
Journal of Gastrointestinal Oncology|December 3, 2013
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancerGary Y Yang, Nadia K Malik, Rameela Chandrasekhar, et al.
Pharmacological Research|May 12, 2009
Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including humanMark S Warren, Noa Zerangue, Katie Woodford, et al.
BMJ (Clinical Research Ed.)|March 22, 2013
Act now against new NHS competition regulations: an open letter to the BMA and the Academy of Medical Royal Colleges calls on them to make a joint public statement of opposition to the amended section 75 regulationsJacky Davis, Ian Banks, David Wrigley, et al.
Pageof 4